Suppression of FVIII-Specific Memory B Cells by Chimeric BAR Receptor-Engineered Natural Regulatory T Cells
Anti-drug antibody formation poses tremendous obstacles for optimal treatment of hemophilia A (HA). In this study, we sought to utilize chimeric receptor-modified natural regulatory T cells (Tregs) to target FVIII-specific memory B cells, which are responsible for persistent anti-FVIII neutralizing...
Main Authors: | Alessandra De Paula Pohl, Shivaprasad H. Venkatesha, Ai-Hong Zhang, David W. Scott |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-04-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2020.00693/full |
Similar Items
-
FVIII Immunity : early events and tolerance mechanisms to FVIII
by: Qadura, Mohammad Imad
Published: (2008) -
From IgG Fusion Proteins to Engineered-Specific Human Regulatory T Cells: A Life of Tolerance
by: David W. Scott
Published: (2017-11-01) -
TGF-β/IL-7 Chimeric Switch Receptor-Expressing CAR-T Cells Inhibit Recurrence of CD19-Positive B Cell Lymphoma
by: Kyung-Eun Noh, et al.
Published: (2021-08-01) -
Immunotherapy for B-Cell Neoplasms using T Cells expressing Chimeric Antigen Receptors : From antigen choice to clinical implementation
by: Mohamed-Rachid Boulasse, et al.
Published: (2012-08-01) -
T Follicular Regulatory Cell Suppression of T Follicular Helper Cell Function Is Context-Dependent in vitro
by: Maria Lopez-Ocasio, et al.
Published: (2020-04-01)